|
Author/year | Type of devices used | Antithrombotic used after device implant | Duration of anticoagulation | Duration of antiplatelet |
|
Ajmal/2020 | Watchman | VKA 11 DOACs 5 | 1.5 | DAPT 4.5 mo ASA lifelong |
|
Fayos-vidal/2020 | Amplatzer Amulet 7 Amplatzer Cardiac Plug 2 | ASA or clopidogrel 5 Not reported 4 | N/A | 6 months single agent |
|
Pouru/2020 | Watchman 2 Amplatzer Amulet 60 Amplatzer Cardiac Plug 42 | VKA 1 DOAC 10 LMWH 23 ASA 72el 4 ASA + clopidogrel 19 ASA + dipyridamole 2 ASA + Plavix + dipyridamole 2 | ≤14 days in 17 pts (50%) ≤1 month in 31 pts (91%) | Clopidogrel ≤ 1 month in 21 pts ASA for ≤6 months in 62 pts After 6 months ASA 28, ASA + dipyridamole 4 |
|
Hucker/2019 | Watchman | VKA 18 DOAC 32 OAC + ASA 27 (out of 50 on OAC) DAPT 12 | 1.5 | DAPT 4.5 mo ASA lifelong |
|
Hutt/2019 | Watchman | VKA 21 (55%) DOAC 17 (45%) | 1.5 | DAPT for 4.5 months 15 ASA lifelong |
|
Nielsen-Kudsk/2017 | Amplatzer Cardiac Plug and Amplatzer Amulet | Clopidogrel 64 (62.1%) ASA 36 (31.1%) None 7 (6.8%) | N/A | 6 months |
|
Tzikas/2017 | Amplatzer Amulet | DOAC 3, VKA 14 Clopidogrel 10, ASA + LMWH 6, ASA + DOAC 1 ASA + VKA 9, DAPT 22, ASA84, triple therapy 1, LMWH 24, no treatment 24 | Not reported | Not reported |
|
Renou/2017 | Watchman and Amplatzer Cardiac Plug used; no numbers given | DAPT 1 ASA 43 | N/A | DAPT 6 months ASA lifelong |
|
Martínez-Domeño/2017 | 2 Amplatzer Amulet 7 Amplatzer Cardiac Plug | 5 Plavix, 4 aspirin | N/A | Not reported |
|
Cru-Gonzal/2017 | Watchman 24, Amplatzer Amulet 21 Amlatzer Cardiac Plug 2 | DAPT 38 LMWH 2 Clopidogrel 1 ASA 4 | 1.5 | 1.5 |
|
Fahmy/2016 | Watchman 9 Amlatzer Amulet 5 Amlatzer Cardiac Plug 12 | DAPT 24 Clopidogrel 1 ASA 1 | N/A | 12 DAPT 1 mo 11 DAPT 3 mo 1 DAPT 6 mo |
|
Horstman/2014 | Amplatzer Cardiac Plug | VKA 1 DAPT 3 mo | 3 mo | DAPT 19 ASA lifelong |
|